New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

PBEvsIBBQETF Comparison

ETF 1
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+0.97%
VS
ETF 2
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
+0.14%

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Invesco Nasdaq Biotechnology ETF (IBBQ) is part of the US Health Care segment. PBE's top 1 sector exposures are Healthcare. In contrast, IBBQ's top sector exposures are Healthcare and Non-Energy Materials. PBE is more expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.19% for IBBQ. PBE is up 22.24% year-to-date (YTD) with +$113M in YTD flows. IBBQ performs better with 23.33% YTD performance, and +$38M in YTD flows. Run a side-by-side ETF comparison of PBE and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBE vs IBBQ performance and flow charts

Performance

-6.0-4.0-2.00.02.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

0 M5 M10 MSep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/26/2026
1M3MYTD1Y3Y5Y
Perf.
PBE
IBBQ
+2.00%-1.52%
+10.62%+7.85%
+22.24%+23.33%
+36.49%+33.67%
+87.45%+91.50%
+34.51%+45.44%
Flows
PBE
IBBQ
-$947K+$14M
+$111M+$35M
+$113M+$38M
+$115M+$55M
+$62M+$74M
+$65M+$52M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBE
IBBQ
+21.57%+25.69%
+20.01%+22.47%
+20.66%+21.24%
+22.69%+22.22%
Max drawdown
PBE
IBBQ
-5.97%-8.58%
-11.70%-8.58%
-22.21%-23.78%
-32.63%-34.86%
Max drawdown duration
PBE
IBBQ
46d68d
166d68d
324d375d
1468d1429d
Trading data

Create an account to view trading data

Join for free
PBE
IBBQ
Last sale
10/27/2026 at 1:30 PM
$100.74
$35.38
Previous close
10/26/2026
$99.21
$34.68
Consolidated volume
10/26/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PBE
IBBQ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
PBE
IBBQ
Last price
$100.74
$35.38
1D performance
+1.54%
+2.01%
AuM$431.86 M$115.51 M
E/R0.59%0.19%
Characteristics
PBE
IBBQ
Management strategyPassivePassive
ProviderInvescoInvesco
BenchmarkDynamic Biotech & Genome Intellidex IndexNASDAQ Biotechnology Index
N° of holdings30249
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005June 9, 2021
ESGNoNo
Advertisement
Exposure

Countries

PBE
USA
97.22%
Other
2.78%
IBBQ
USA
88.22%
Other
11.78%

Sectors

PBE
Healthcare
100%
Other
0%
IBBQ
Healthcare
99.99%
Other
0.01%
Advertisement

Diversification

PBE

Total weight of top 15 holdings out of 15

63.67%
IBBQ

Total weight of top 15 holdings out of 15

52.06%

Top 15 holdings

Data as of August 31, 2026
PBE
CareDx, Inc.
5.49%
Amgen, Inc.
5.38%
Regeneron Pharmaceuticals, Inc.
5.26%
Vertex Pharmaceuticals, Inc.
5.21%
Royalty Pharma Plc
4.76%
Biogen, Inc.
4.75%
Gilead Sciences, Inc.
4.61%
United Therapeutics Corp.
3.77%
Omeros Corp.
3.73%
Repligen Corp.
3.57%
Illumina, Inc.
3.54%
Halozyme Therapeutics, Inc.
3.51%
Bio-Techne Corp.
3.41%
Protagonist Therapeutics, Inc.
3.37%
Alnylam Pharmaceuticals, Inc.
3.31%
IBBQ
Amgen, Inc.
8.60%
Vertex Pharmaceuticals, Inc.
8.10%
Gilead Sciences, Inc.
7.34%
Regeneron Pharmaceuticals, Inc.
5.26%
Moderna, Inc.
3.58%
Revolution Medicines, Inc.
2.97%
Illumina, Inc.
2.18%
Biogen, Inc.
2.07%
Alnylam Pharmaceuticals, Inc.
2.00%
argenx SE
1.84%
Royalty Pharma Plc
1.73%
Roivant Sciences Ltd.
1.71%
Insmed, Inc.
1.66%
Incyte Corp.
1.61%
United Therapeutics Corp.
1.42%
Frequently asked questions about PBE and IBBQ

How have the PBE and IBBQ ETFs performed in 2026?

As of October 26, 2026, PBE is up 22.24% year-to-date (YTD), while IBBQ has returned 23.33%. That puts IBBQ better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or IBBQ?

Year-to-date, the PBE ETF saw +$113M in flows, compared to +$38M for IBBQ.

Which ETF is more volatile: PBE or IBBQ?

Over the past year, PBE had a volatility of 20.01%, while IBBQ experienced 22.47%.

Which ETF is bigger: PBE or IBBQ?

As of October 26, 2026, PBE holds $431.86 M in assets under management (AUM), while IBBQ manages $115.51 M.

What sectors do the PBE and IBBQ ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, IBBQ focuses on Healthcare.

What are the top holdings of the PBE ETF and IBBQ ETF?

PBE top holdings include CareDx, Inc., Amgen, Inc. and Regeneron Pharmaceuticals, Inc.. IBBQ holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..

Which ETF is more diversified: PBE or IBBQ?

PBE holds 30 securities with 63.67% of its assets in the top 15. IBBQ has 249 securities and a top 15 weight of 52.06%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026